Johns Hopkins Cystic Fibrosis Center

Johns Hopkins CF Center

 Search Chat Schedule an Appointment Contact Us Ways to Give
Site Tools Navigation

CF Main Site

CF forCF for Teens

CF for Kids

About Us

What is CF?

Living with CF

Research

Newsroom

Home

What is CF?

Overview
Basic Science
   - CFTR
        - Structure
        - Function
        - Cellular Processing
        - Mutations
   Other Ion Channels
   Lung Problems
        - Bacteria/Infection
        - Inflammation
        - Lung Damage
  
Gastrointestinal Tract 
      Problems

        - What Enzymes Do
        - Malabsorption

Diagnosis
Effects of CF
Treatments
CF A to Z
Partners in Discovery
Ask the Experts

Basic Science: GI Tract Problems: Malabsorption
Printer-Friendly Version

Malabsorption of essential nutrients is characterized in CF by poor weight gain, growth retardation, delayed puberty, and muscle wasting.

Patients with CF need to be frequently monitored because nutritional needs change with disease progression and normal growth. To maintain a desirable body weight and prevent or correct nutritional deficiencies, CF patients might have to consume twice as many calories as recommended for healthy children and adults. Increasing the intake of calories can also aid in adequate fat, vitamin, and mineral absorption.
 
Nutritional therapy helps prevent complications, such as glucose intolerance, intestinal obstruction, cirrhosis, and pancreatic disease. Vitamin and mineral supplements such as the fat-soluble vitamins A, D, E, and K are often used. Since these vitamins use dietary fat is necessary for absorption of these vitamins, high-fat food consumption is often encouraged. Fat is also the most concentrated source of calories and improves the palatability of foods, and with caloric needs so high in CF patients, this becomes essential. Protein deficiencies are most likely to occur during periods of growth and infection.

Patients with untreated pancreatic insufficiency commonly have profound malabsorption of bile. Up to 60 percent of adolescents and adults with CF have gallbladder abnormalities. Treatment of pancreatic insufficiency with pancreatic enzymes will decrease bile acid loss, thus decreasing the risk of gall stones. If gall stones are forming, ursodeoxycholic  acid (ursodiol) therapy is used to help dissolve the stones and increase cholesterol production in the liver.

Back to Top

Johns Hopkins Children's Center

Johns Hopkins Medicine

© 2006 Johns Hopkins Medicine  |  Terms & Privacy  |  About this Site